Collaborate to accelerate drug discovery

What we do

We develop potential therapeutics through our extensive researcher and foundation networks.

We identify research that can be readily translated to treatments for rare and neglected diseases.

We provide the drug discovery preclinical and clinical expertise to move therapeutics towards the clinic.

We can help you by providing our expertise for your grant submission. For example we recently won an SBIR with PsychoGenics.

To find out more about our capabilities please contact us

How we report on a project

Understand what the customer wants

Understand the problem and not just what our models can do

Clearly describe what we did

What did we find?

How does this benefit the company?

How can we build on this work for the company?

Provide graphical representations of the data

Highlight the advantages and acknowledge limitations

What we have delivered

We have obtained 9 orphan drug designations .

We have delivered measurable results for our collaborators and clients.

We have widely published our results in respected peer reviewed journals.


Client Use Cases


We collaborate with other groups to address complex diseases

For example, we recently announced a new grant to help PsychoGenics design new drugs for mental health disorders.